Innospec Q2 2024 Earnings Report
Key Takeaways
Innospec Inc. reported a decrease in revenue by 9 percent to $435.0 million compared to the previous year. Net income increased to $31.2 million, with GAAP EPS at $1.24 and adjusted non-GAAP EPS at $1.39. The company's adjusted EBITDA was $54.1 million, and it maintains a debt-free balance sheet with over $240 million in net cash.
Performance Chemicals operating income more than doubled due to growth in personal care.
Fuel Specialties operating income increased double digits with margin expansion.
Oilfield Services results were negatively impacted by lower production chemical activity.
The company maintains a debt-free balance sheet with over $240 million in net cash.
Innospec
Innospec
Innospec Revenue by Segment
Forward Guidance
Innospec anticipates maintaining improved results in the second half of 2024, with focus on technology-led growth opportunities. Oilfield Services expects lower sales levels to continue through the second half of 2024.
Positive Outlook
- Excitement for opportunities in all end-markets.
- Cautious optimism to maintain improved results in the second half of 2024.
- QGP Quimica acquisition performing in line with expectations and well positioned for growth.
- Targeting further sales growth and margin improvement in Fuel Specialties.
- Focus on technology-led growth opportunities.
Challenges Ahead
- Oilfield Services results impacted by significantly lower production chemical activity.
- As of the end of July this activity has not recovered.
- Expect to see lower sales levels continuing through the second half of 2024 in Oilfield Services.
- Oilfield Services results are below targeted range.
- Potential remains for some near-term recovery in Oilfield Services.
Revenue & Expenses
Visualization of income flow from segment revenue to net income